Fibrobiologics Inc (FBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,827 | 5,973 | 8,158 | 9,163 | 0 |
| Other current assets | 18 | 18 | 18 | 16 | 0 |
| TOTAL | $8,198 | $6,509 | $8,922 | $9,215 | $0 |
| Non-Current Assets | |||||
| PPE Net | 772 | 799 | 770 | 797 | N/A |
| Other Non-Current Assets | 1,499 | 1,604 | 1,707 | 1,809 | 0 |
| TOTAL | $2,271 | $2,403 | $2,477 | $2,606 | $N/A |
| Total Assets | $10,469 | $8,912 | $11,399 | $11,821 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,042 | 3,149 | 2,814 | 1,444 | 0 |
| Other current liabilities | 3,128 | 6,314 | 10,340 | 7,236 | 0 |
| TOTAL | $6,677 | $10,132 | $13,985 | $9,183 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,055 | 1,167 | 1,277 | 1,385 | 0 |
| TOTAL | $1,055 | $1,167 | $1,277 | $1,385 | $N/A |
| Total Liabilities | $7,732 | $11,299 | $15,262 | $10,568 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,733 | 1,758 | 1,636 | N/A | N/A |
| Common Shares | N/A | N/A | N/A | 1 | 0 |
| Retained earnings | -32,419 | -31,919 | -32,817 | -24,357 | 0 |
| TOTAL | $2,737 | $-2,387 | $-3,863 | $1,253 | $0 |
| Total Liabilities And Equity | $10,469 | $8,912 | $11,399 | $11,821 | $0 |